Details for New Drug Application (NDA): 065078
✉ Email this page to a colleague
NDA 065078 describes CYCLOSPORINE, which is a drug marketed by Apotex, Dr Reddys Labs Sa, Ivax Sub Teva Pharms, Sandoz, Strides Pharma, Deva Holding As, Mylan, Saptalis Pharms, Teva Pharms Usa Inc, Hikma, Padagis Us, Abbvie, Pharm Assoc, and Pharmobedient Cnsltg, and is included in eighteen NDAs. It is available from ten suppliers. Additional details are available on the CYCLOSPORINE profile page.
The generic ingredient in CYCLOSPORINE is cyclosporine. There are eighteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.
The generic ingredient in CYCLOSPORINE is cyclosporine. There are eighteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.
Summary for 065078
| Tradename: | CYCLOSPORINE |
| Applicant: | Ivax Sub Teva Pharms |
| Ingredient: | cyclosporine |
| Patents: | 0 |
Pharmacology for NDA: 065078
| Mechanism of Action | Calcineurin Inhibitors Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors |
Medical Subject Heading (MeSH) Categories for 065078
Suppliers and Packaging for NDA: 065078
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CYCLOSPORINE | cyclosporine | SOLUTION;ORAL | 065078 | ANDA | Teva Pharmaceuticals USA, Inc. | 0172-7313 | 0172-7313-20 | 1 BOTTLE in 1 PACKAGE (0172-7313-20) / 50 mL in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | 100MG/ML | ||||
| Approval Date: | Mar 25, 2005 | TE: | AB1 | RLD: | No | ||||
Complete Access Available with Subscription
